Literature DB >> 23715570

Erythema nodosum-like panniculitis in patients with melanoma treated with vemurafenib.

Rishika Sinha1, Kim Edmonds, Julia Newton-Bishop, Martin Gore, James Larkin, Louise Fearfield.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23715570     DOI： 10.1200/JCO.2012.45.8307

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  6 in total

Review 1.  Managing the skin toxicities from new melanoma drugs.

Authors:  John C Mavropoulos; Timothy S Wang
Journal:  Curr Treat Options Oncol       Date:  2014-06

2.  [Cutaneous side effects of anti-tumor therapy with BRAF and MEK inhibitors].

Authors:  R Gutzmer; J C Hassel; K C Kähler; C Loquai; R Mössner; S Ugurel; L Zimmer; Für Komitee Kutane Nebenwirkungen Ado der das Ado
Journal:  Hautarzt       Date:  2014-07       Impact factor: 0.751

Review 3.  BRAF inhibitors: experience in thyroid cancer and general review of toxicity.

Authors:  M E Cabanillas; A Patel; B P Danysh; R Dadu; S Kopetz; G Falchook
Journal:  Horm Cancer       Date:  2014-12-03       Impact factor: 3.869

4.  Panniculitis Associated with MEK Inhibitor Therapy: An Uncommon Adverse Effect.

Authors:  Miruna Negulescu; Florian Deilhes; Vincent Sibaud; Emilie Tournier; Laurence Lamant; Serge Boulinguez; Nicolas Meyer
Journal:  Case Rep Dermatol       Date:  2017-03-21

5.  Delayed-onset vemurafenib-induced panniculitis.

Authors:  Stephen L Vance; Hannah M Singer; David Silvers; Sameera Husain; Filamer Kabigting
Journal:  JAAD Case Rep       Date:  2017-08-30

6.  Clinicopathological Characteristics Related to Etiologies of Erythema Nodosum: A 10-Year Retrospective Study.

Authors:  Preeyachat Limtong; Poonkiat Suchonwanit; Kumutnart Chanprapaph; Suthinee Rutnin
Journal:  Clin Cosmet Investig Dermatol       Date:  2021-11-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.